Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Early Age-Related Hearing Loss Investigation (EARHLI)

NCT: NCT06174038 · RECRUITING

NCT IDNCT06174038
StatusRECRUITING
Start Date2024-08-01
Completion2027-12-31
SponsorColumbia University (OTHER)
First posted
Last updated

Brief Summary

Early Age-Related Hearing Loss Investigation (EARHLI) is a single site study that will randomize late middle age adults to either a hearing intervention (including hearing aids) or a health education intervention. Participants will be followed for 1 year. This study will provide information on reducing cognitive decline in those at risk for Alzheimer's Disease and Alzheimer's Disease Related Dementias (AD/ADRD).

Frequently Asked Questions

What is Early Age-Related Hearing Loss Investigation (EARHLI)?

Early Age-Related Hearing Loss Investigation (EARHLI) is a clinical trial registered under NCT06174038. Current status: RECRUITING.

What is the status of NCT06174038?

The current status of NCT06174038 (Early Age-Related Hearing Loss Investigation (EARHLI)) is: RECRUITING.

When did Early Age-Related Hearing Loss Investigation (EARHLI) start?

Early Age-Related Hearing Loss Investigation (EARHLI) started on 2024-08-01.

Related Devices

K192073Helix Genetic Health Risk App for late-onset Alzheimer’s diseaseHelix Opco, LLC

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑